Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Index level declines can reflect profit-taking, macro shocks, or sector rotations. This intro covers common indicators to read with context.
23,215 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Mid-June market data show the Russell 2000 leading the pack, up around 18% year-to-date as small caps take the spotli...
When promises of guaranteed principal collide with real market risk, investors can lose more than money. This article...
Retirees still need a cash cushion. This guide shows how to build an emergency fund that stays accessible, protects s...
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Gen-Z prioritizes financial security and easy retirement access over office social events. A new Edward Jones/Morning...
Investors are buzzing about SpaceX going public and what the first earnings report might reveal. Here are four core a...
Micron’s shares fell about 12% at the open amid a broad market rout. Yet analysts see a longer-term memory shortage d...
Cerebras Systems stock crashed after its latest earnings report, leaving investors asking what happened and what come...
SpaceX remains privately held, but chatter about a public listing fuels the myth that a superstar IPO will power the ...
The AI memory boom has traders watching the Roundhill Memory ETF. With a potential SK Hynix ADR list around July 10, ...
The Federal Reserve’s annual stress tests show 32 large banks surviving a severe unemployment shock, with capital cus...